富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/05/28 | 日証協 | 155,504株 | +117.78% | 121,700株 | +72.14% | 249,594株 | +0.89% | 141,700株 | +279.89% |
2021/05/21 | 日証協 | 71,404株 | -17.55% | 70,700株 | +4.74% | 247,394株 | +13.33% | 37,300株 | -37.63% |
2021/05/14 | 日証協 | 86,604株 | +67.99% | 67,500株 | +88.11% | 218,294株 | +31.48% | 59,800株 | +382.26% |
2021/05/07 | 日証協 | 51,554株 | -16.92% | 35,883株 | +29.54% | 166,028株 | -10.17% | 12,400株 | -65.27% |
2021/04/30 | 日証協 | 62,054株 | +1.64% | 27,700株 | -57.57% | 184,828株 | +10.46% | 35,700株 | +134.47% |
2021/04/23 | 日証協 | 61,054株 | +47.22% | 65,283株 | +82.87% | 167,328株 | -2.69% | 15,226株 | -33.9% |
2021/04/16 | 日証協 | 41,471株 | -41.89% | 35,700株 | -56.25% | 171,945株 | -18.06% | 23,035株 | -50.99% |
2021/04/09 | 日証協 | 71,371株 | -8.8% | 81,600株 | +13.97% | 209,845株 | +13.72% | 47,000株 | -60.1% |
2021/04/02 | 日証協 | 78,261株 | +12.86% | 71,600株 | -49.14% | 184,535株 | +17.67% | 117,801株 | +60.95% |
2021/03/26 | 日証協 | 69,344株 | +58.52% | 140,785株 | +143.15% | 156,826株 | +11.4% | 73,191株 | +184.34% |
2021/03/19 | 日証協 | 43,744株 | +17.77% | 57,900株 | +72.32% | 140,778株 | +1.3% | 25,741株 | +99.54% |
2021/03/12 | 日証協 | 37,144株 | +25.3% | 33,600株 | +28.74% | 138,978株 | -6.84% | 12,900株 | -27.93% |
2021/03/05 | 日証協 | 29,644株 | -11.1% | 26,100株 | -27.7% | 149,178株 | +2.9% | 17,900株 | -13.94% |
2021/02/26 | 日証協 | 33,344株 | -30.6% | 36,100株 | -55.58% | 144,978株 | -6.03% | 20,800株 | +48.57% |
2021/02/19 | 日証協 | 48,044株 | -33.86% | 81,275株 | +3.67% | 154,278株 | -16.95% | 14,000株 | -70.82% |
2021/02/12 | 日証協 | 72,644株 | -2.62% | 78,400株 | -37.35% | 185,758株 | -0.4% | 47,970株 | +111.36% |
2021/02/05 | 日証協 | 74,598株 | -18.56% | 125,132株 | +6.09% | 186,512株 | -13.21% | 22,696株 | +17.6% |
2021/01/29 | 日証協 | 91,598株 | -15.11% | 117,949株 | -27.06% | 214,912株 | -8.2% | 19,300株 | -18.22% |
2021/01/22 | 日証協 | 107,898株 | -15.01% | 161,698株 | +81.48% | 234,112株 | -10.87% | 23,600株 | +321.43% |
※株式分割は考慮していませんのでご注意ください。
Page Top